Loading GYRE company information
Open the financials tab to load SEC data
Loading GYRE data
Loading GYRE data
Loading GYRE data
Loading GYRE data
Loading GYRE data
Few overheating or already-surging signals — relatively calm. A good stage to observe pre-breakout conditions patiently.
Some risk factors present — volatility, short-term overheating, or thin liquidity. Size and scale in carefully if entering.
Already surged, RSI overheated, extended far from highs, or earnings imminent. Chasing now carries meaningful pullback risk.
GYRE's RSI(14) currently reads 31. RSI is a momentum indicator that reflects how often and how sharply a stock has been rising lately. Readings above 70 are typically read as overbought and below 30 as oversold — this one falls in the 'oversold' range. This reading is specific to GYRE on this scan date and can change quickly. → Learn more
ADX currently reads 25. ADX tells you how convincing a trend is, leaving the up-or-down call to +DI/-DI (25+ is considered pronounced). Right now GYRE shows +DI and -DI show no clear edge either way, putting it in the 'strong trend' range on ADX. This reading is specific to GYRE on this scan date and can change quickly. → Learn more
GYRE's Bollinger Band width is in the top 10% (wide) of its past year, and the squeeze indicator is not currently active. Band-width contraction (a squeeze) means the stock has been trading in an unusually tight range lately. A squeeze is often followed by a volatility expansion in either direction. This reading is specific to GYRE on this scan date and can change quickly. → Learn more
GYRE's OBV is currently not showing a clear rise (none), and the up/down volume ratio is 1.3x. OBV (On-Balance Volume) uses the cumulative direction of volume to estimate accumulation or distribution. Cross-check this against GYRE's other indicators above before drawing a conclusion. → Learn more
GYRE's recent volume is running at 1.2x its usual level. This ratio shows how many times normal volume the stock has been trading at lately — a reference point for whether order flow is concentrating around this stock. Treat this as one data point on GYRE, not a standalone signal. → Learn more
GYRE's change over the last 5 trading days is -3.8%, and over the last 1 trading day is -0.2%. These two numbers show recent short-term direction but say nothing about where the price goes next.
GYRE's current price is 24.4% below its 20-day high. It shows how much room remains between the current price and its own 20-day high-water mark. On this measure it currently falls in the 'distance from high' category. As with any single metric, weigh this alongside GYRE's full indicator set. → Learn more
GYRE's ATR% currently reads 5.0%, a 'daily range' level. ATR captures typical day-to-day volatility in dollar (here, percentage) terms. This reading is specific to GYRE on this scan date and can change quickly. → Learn more
GYRE's 20-trading-day relative strength versus SPY (S&P 500 ETF) is -18.9%. GYRE gained less (or lost more) than SPY over this stretch. As with any single metric, weigh this alongside GYRE's full indicator set. → Learn more
Measured (n=2971), the hit-rate for Stochastic Oversold Reversal (27.0%) was not statistically distinguishable from the base rate (24.7%). As with any single metric, weigh this alongside GYRE's full indicator set. → Stochastic Oversold Reversal
Measured (n=11420), the hit-rate for ADX Trend Strengthening (24.5%) was not statistically distinguishable from the base rate (24.7%). Treat this as one data point on GYRE, not a standalone signal. → ADX Trend Strengthening
Stocks holding Avg Daily Range 4%+ reached +15% 42.3% of the time, versus a 24.7% base rate — not a statistically significant difference (6868 cases). This reading is specific to GYRE on this scan date and can change quickly. → Avg Daily Range 4%+
Limitations of this page — Automatically calculated, not a stock recommendation. Score is a count of conditions met, not a prediction; base rates are historical measurements only (GYRE diagnostic as of 2026.10.24 16:46).
A history of past monitoring candidates — not investment advice. See the scanner's full track record here.